disease, 2 with pleural disease, and 1 each with paravertebral, meningeal, genital, bladder, enteric, and bone disease.
Anti-tumor necrosis factor receptor and tumor necrosis factor agonist activity by an anti-idiotypic antibody
✍ Scribed by Cynthia J. Galloway; Melanie S. Madanat; Timothy Sarr; Terje Espevik; Michael L. Dumas; George Mitra; Gerald E. Ranges
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 403 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## I 73 has been reported to recur after liver transplantation (Hepatology 1993;18:1392). The authors of the current study state that based on the results of their study, they "would not recommend empirical therapy with ursodiol for patients with primary sclerosing cholangitis." The results of th
## Abstract Sepsis is a harmful hyper‐inflammatory state characterized by overproduction of cytokines. Removal of these cytokines using an extracorporeal device is a potential therapy for sepsis. We are developing a cytokine adsorption device (CAD) filled with porous polymer beads which efficiently
Recombinant human tumor necrosis factor (rHuTNF) was investigated for its ability to increase the response of murine tumors to ionizing radiation. Both multiple i.v. administrations of rHuTNF and local tumor irradiation caused a significant delay in tumor growth. The effect of treatment with both ag